Johnson & Johnson just posted a quarter that sent shares sliding despite a headline beat, yet analysts keep piling into the bull camp with price targets well above current levels. Here is…
Raising dividends through two recessions takes more than a good brand name. Three companies with streaks stretching back decades show exactly what separates a payout that survives a crisis from one that…
AbbVie's stock has surged nearly 29% this year, but a rising share price compresses the yield even as the dividend keeps growing. Before adding shares for income, consider what the pending Apogee…
When tech stocks crack, most investors discover too late that their portfolios were far more concentrated than they realized. Jim Cramer and others are pointing to a handful of quiet winners that…
A dividend that keeps growing beats a fat yield that gets cut, but only if the company can actually afford to keep raising it. These five blue chips clear that bar, and…
Most investors chase the highest yield they can find, but that single decision quietly destroys the income they worked to build. A three-bucket approach solves a tension most dividend strategies ignore entirely.
Kevin O'Leary's retirement playbook starts with a warning that catches most people off guard, and it has nothing to do with stocks or bonds. His three rules draw a hard line between…
Johnson and Johnson crushed earnings, raised guidance, and still watched its stock crater nearly 6% in a single session. Understanding what spooked investors reveals whether Tuesday's selloff is a trap or a…
Every big pharma company eventually watches its best-selling drug go generic, yet some keep raising their dividends anyway. The five names on this list have already replaced their fading blockbusters with something…
Most people reach for the 4% rule when they picture retiring at 56 on nearly $6,000 a month, but that rule answers a completely different question than a dividend portfolio does, and…
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) stock is at $249.55, down 5% early in the session. The company raised its full-year outlook in the same release that showed its reported…
VYM's trailing yield sits well below what a 10-year Treasury pays today, yet the fund keeps attracting billions in new assets. The reason comes down to what bonds cannot offer and what…
Four Dividend Kings have raised their payouts for decades, but a closer look at their cash flows reveals one payout hanging by a thread while another faces a looming tax battle that…
Treasury bills guarantee your rate until maturity while Johnson and Johnson has raised its dividend for 64 straight years, but depending on your tax state and timeline, one of these income streams…
Chris Lange Two healthcare giants drop their third-quarter numbers on the same morning, and what each reveals about drug costs, insurance margins, and guidance ranges will set the tone for the entire sector heading…
